Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Hotshot85on Apr 20, 2021 9:39am

129 Views

Post# 33028148

Investment Advice

Dont take advice on buying or selling from anyone on these boards. Differing opinions are fine to seek out but making a buy or sell choice from any knucklehead with a keyboard is disasterous.

Have a plan, do your research, stick to your plan. You never go broke making money. 1%, 2%, 50%.

I love that i could wake up any morning and this stock could be $20. Seems like the floor is baked in here. Only question is what happen with dilution.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals